1 Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice

2 Maternal influenza and birth outcomes: systematic review of comparative studies

3 Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 - 2016

4 Interferon in nasal secretions from infants with viral respiratory tract infections

5 Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

6 H5N1 infection of the respiratory tract and beyond: a molecular pathology study

7 Viral load in patients infected with pandemic H1N1 2009 influenza A virus

8 Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies

9 Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus

10 Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus

11 Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses

12 Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide

13 Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009

14 Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets

15 Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons

16 Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

17 Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China

18 The pathology of influenza virus infections

19 Factors associated with early hospital discharge of adult influenza patients

20 Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

21 Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques

22 Avian influenza virus infections in humans

23 Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza

24 The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor

25 IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge

26 Confirmation of the first Hong Kong case of human infection by novel swine origin influenza A (H1N1) virus diagnosed using ultrarapid, real-time reverse transcriptase PCR

27 Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice

28 Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)

29 Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction

30 Drug resistance in influenza A virus: the epidemiology and management

31 Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase

32 Drug resistance in influenza A virus: the epidemiology and management

33 CD206+ Cell Number Differentiates Influenza A (H1N1)pdm09 from Seasonal Influenza A Virus in Fatal Cases

34 Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity

35 p-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo.

36 Evidence of the Presence of Low Pathogenic Avian Influenza A Viruses in Wild Waterfowl in 2018 in South Africa.

37 Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.

38 Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins

39 Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice

40 [The Effects and Mechanisms of Dihydroartemisinin on Influenza A Virus H1N1 Induces TNF-α and IL-6 Expression in Bronchial Epithelial Cells].

41 Obesity Increases the Duration of Influenza A Virus Shedding in Adults

42 Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009

43 immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza a virus

44 experimental approaches to study genome packaging of influenza a viruses

45 a case for rimantadine to be marketed in canada for prophylaxis of influenza a virus infection

46 attenuated recombinant influenza a virus expressing hpv16 e6 and e7 as a novel therapeutic vaccine approach.

47 correction: attenuated recombinant influenza a virus expressing hpv16 e6 and e7 as a novel therapeutic vaccine approach.

48 ns segment of a 1918 influenza a virus-descendent enhances replication of h1n1pdm09 and virus-induced cellular immune response in mammalian and avian systems

49 in vitro anti-viral activity of psoraleae semen water extract against influenza a viruses

50 comparative studies on two tests for detection of avian influenza a virus and newcastle disease virus in co-infected guinea fowl (numida meleagris)

51 amino acid substitution k470r in the nucleoprotein increases the virulence of h5n1 influenza a virus in mammals

52 Spread of influenza A virus infection in hospitalised patients with cancer

53 Antiviral agents active against influenza A viruses

54 Resistant influenza A viruses in children treated with oseltamivir: descriptive study

55 Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

56 Epidemiology of influenza A virus infection in patients with acute or chronic leukemia

57 Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

Keyword Connections

Journals

Research Groups

Bibliographies